Chapter 27 Review Questions

Question 1

The incidence rate of bone cancer is highest during what period?

a. Infancy
b. Adulthood
c. Adolescence
d. Equal for all age

Answer 1

c. Adolescence

Question 2

A nonosseous malignant tumor of the marrow is a(an):

a. fibrosarcoma.
b. chondrosarcoma.
c. osteosarcoma.
d. multiple myeloma

Answer 2

d. multiple myeloma

Question 3

A bone lesion that results from primary sites elsewhere in the body is a(n):

a. osteosarcoma.
b. multiple myeloma.
c. metastatic tumor.
d. chondrosarcoma.

Answer 3

c. metastatic tumor.

Question 4

The most common site of a primary bone sarcoma is:

a. epiphyseal.
b. metaphyseal.
c. diaphyseal.
d. shaft.

Answer 4

a. epiphyseal.

Question 5

Prognostic indicators for patients with primary bone cancer include all of the following except:

a. age.
b. gender.
c. location.
d. weight

Answer 5

b. gender.

Question 6

The most common site of metastasis from primary bone cancer is:

a. brain.
b. bowel.
c. lung.
d. distal extremities

Answer 6

c. lung.

Question 7

_________________ is most commonly used in treating metastatic bone disease that results from primary prostate or breast cancer.

a. Technetium-99m
b. Iodine-131m
c. Strontium-89m
d. Iodine-125m

Answer 7

c. Strontium-89m

Question 8

Although the exact cause of STS is unknown, a factor that has been implicated is:

a. prior sun exposure.
b. appearance as a second primary 5 to 15 years after high-dose radiation therapy for other cancers.
c. predisposition of Paget’s disease.
d. tobacco use

Answer 8

b. appearance as a second primary 5 to 15 years after high-dose radiation therapy for other cancers.

Question 9

Factors or clinical signs that are incorporated in the staging systems and considered appropriate as general prognostic indicators for STS include: 
I.  histology. 
II.  size. 
III.  gender. 
a.  I and II 
b.  I and III 
c.  II and III 
d.  I, II, and III

Answer 9

a. I and II

Question 10

Regional lymph nodes are generally not included in the treatment portals for STS. Which of the following are exceptions for this statement? 
I.  Rhabdomyosarcoma 
II.  Synovial sarcoma 
III.  Leiomyosarcoma 
a.  I and II 
b.  I and III 
c.  II and III 
d.  I, II, and III

Answer 10

a. I and II